Showing 1 - 3 of 3
Patients to gain cancer drug access
News, Post Reporters, Published on 04/12/2025
» The government has approved new reimbursement rules enabling patients with advanced non-small cell lung cancer (NSCLC) to use targeted therapies, Erlotinib or Gefitinib, as first-line treatment, effective for medical expenses incurred from Dec 1 onwards.
PM2.5, gene changes behind lung cancer spike
News, Apinya Wipatayotin, Published on 04/08/2025
» PM2.5 air pollution and mutations in the EGFR gene are major drivers behind the increasing incidence of lung cancer among non-smoking women, particularly across Asia, says a leading Thai oncologist.
BDMS touts AI's role in cancer treatment
News, Oraphin Phangyang, Published on 05/02/2024
» Artificial Intelligence (AI) will play a pivotal role in reducing the mortality rate of lung cancer, according to the Bangkok Dusit Medical Services Public Company Limited (BDMS).